We are live on ! Find out more
NTUS

Natus Medical Inc

Delisted

NTUS was delisted on the 20th of July, 2022.

1 hedge funds and large institutions have $6K invested in Natus Medical Inc in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 182 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 1861 (-185)

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

100% less capital invested

Capital invested by funds: $1.05B → $6K (-$1.05B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 182

Holders
1
Holders Change
-185
Holders Change %
-99.46%
% of All Funds
0.02%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
182
Calls
Puts
Net Calls
Net Calls Change

NTUS Hedge Fund Activity: Q3 2022 in Review

1 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q3 2022, worth a combined $6K — down 100% from $1.05B a quarter earlier.

Sellers outnumbered buyers: 182 funds closed out of NTUS and 0 opened new positions — a net loss of 182 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $207M sold.

  • 1 institutional investor held Natus Medical Inc (NTUS) as of Q3 2022, down from 186 in Q2 2022.
  • Funds reported $6K of Natus Medical Inc stock for Q3 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Natus Medical Inc positions in Q3 2022 and 182 closed out, a net change of -182 holders.
  • The largest Natus Medical Inc seller in Q3 2022 was BlackRock, an estimated $207M sold.

Based on aggregated 13F filings for Q3 2022.